Fremanezumab

4 trials 2 recruiting NNeurology/Psychiatry

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 1

Sponsors using this IMP

Aarhus University Hospital 1 Medizinische Universitaet Innsbruck 1 Oslo University Hospital HF 1 Teva Branded Pharmaceutical Products R&D LLC 1

All trials

4 total

The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr… Recruiting

2024-517981-40-00 Phase III 1 country Oslo University Hospital HF
Fremanezumab for pain in Complex Regional Pain Syndrome Recruiting

2022-503167-15-00 Phase II 1 country Aarhus University Hospital
MR-Spectroscopy: Investigating neurochemical changes in brain metabolism in migraineurs before and after CGRP-Antibody treatment – a randomi… Ended

2024-517079-19-00 Phase IV 1 country Medizinische Universitaet Innsbruck
A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents Ended

2024-512837-34-00 Phase III 6 countries Teva Branded Pharmaceutical Products R&D LLC

Showing 1–4 of 4 trials

← All drugs A–Z